Qualigen Therapeutics's total assets for Q3 2024 were $2.31M, an increase of 332.81% from the previous quarter. QLGN total liabilities were $4.45M for the fiscal quarter, a -7.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.